abstract |
The invention relates to compounds corresponding to formula (I) in which R1a, R1b, R1c, R1d, R2a, R2b, RdC, R2d, R3a, R3b, R4, n, i, j, o, p, qy X are as defined in the description and their use as modulators of 11 β-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome or type 2 diabetes. |